Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 3/20 | 0.34 |
| ▸ | CEL | P19835 | 2/20 | 0.34 |
| ▸ | PDE1A | P54750 | 1/20 | 0.32 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 2/20 | 0.31 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.31 |
| ▸ | HTR6 | P50406 | 1/20 | 0.30 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.30 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.30 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.30 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27672685 | 0.72 | HTR2C (0.42) | CELHTR2CHTR6 | |
| SCHEMBL22183231 | 0.72 | CEL (0.38) | CELHTR2CHTR6 | |
| SCHEMBL14231147 | 0.71 | PIK3CB (0.31) | PDE1APDE1CPIK3CBPIK3CG | |
| SCHEMBL22156301 | 0.70 | PDE1A (0.41) | OPRL1PDE1APDE1C | |
| SCHEMBL21163634 | 0.70 | HTR2C (0.46) | HTR2CHTR6 | |
| SCHEMBL25926930 | 0.69 | MAPK1 (0.42) | OPRL1 | |
| SCHEMBL26530978 | 0.68 | HTR2C (0.62) | OPRL1HTR2CHTR6 | |
| SCHEMBL20777893 | 0.68 | ALDH1A1 (0.43) | OPRL1HTR2CPDCD1CD274 | |
| SCHEMBL27362265 | 0.68 | HTR6 (0.43) | OPRL1HTR2CHTR6 | |
| SCHEMBL22781622 | 0.66 | HTR2C (0.42) | OPRL1HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3672952-B1 | BENZIMIDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS | MERCK PATENT GMBH (DE) | 2022-12-14 | — | — | EP | disclosed |